Application 215995
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 2.5MG;6.25MG | No | No |
| 002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 5MG;6.25MG | No | No |
| 003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 10MG;6.25MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | |
| A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | |
| A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215995-001 | AB |
| A215995-002 | AB |
| A215995-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-002 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-003 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 10MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A215995-001 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2.5MG;6.25MG | TABLET / ORAL | AB | 2022-01-26 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215995-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A215995-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A215995-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215995-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A215995-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215995-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215995-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215995-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215995-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215995-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215995-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A215995-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215995-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215995-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215995-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A215995-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 9271a2d7-be94-4e38-9f71-41e8d55e10bc | 2026-03-03 | Warnings, Adverse reactions | 215995 ANDA215995 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 794d4a5a-de31-4878-95d5-23552dd2171e | 2025-06-04 | Warnings, Adverse reactions | 215995 ANDA215995 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d3e9c30-8dcf-491a-a515-6890b391398e | 2025-05-29 | Warnings, Adverse reactions | 215995 ANDA215995 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | GLENMARK PHARMACEUTICALS INC., USA | ab73a6d8-2e33-4fdc-a896-6c68ab772da6 | 2025-01-06 | Warnings, Adverse reactions | 215995 ANDA215995 68462-880 68462-879 68462-878 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 78df389a-0916-46db-a536-72cae9ad6c08 | 2024-01-02 | Warnings, Adverse reactions | 215995 ANDA215995 50090-6030 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-6030 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | A-S Medication Solutions | ANDA | Current |
| 68462-878 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-878 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-879 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-879 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-880 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-880 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |